A randomized controlled trial of a web-based treatment for social phobia
| ISRCTN | ISRCTN62304985 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN62304985 |
| ClinicalTrials.gov (NCT) | Nil known |
| Clinical Trials Information System (CTIS) | Nil known |
| Protocol serial number | 100011-112345 |
| Sponsor | The Swiss National Science Foundation (Switzerland) |
| Funder | The Swiss National Science Foundation (Grant ref: 100011-112345) |
- Submission date
- 05/03/2007
- Registration date
- 26/09/2007
- Last edited
- 23/05/2019
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Prof Franz Caspar
Scientific
Scientific
40 Blv. du Pont d'Arve
Geneva
1211
Switzerland
| franz.caspar@pse.unige.ch |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial. |
| Secondary study design | Randomised controlled trial |
| Scientific title | A randomized controlled trial of a web-based treatment for social phobia |
| Study acronym | OSP Trial (Online Social Phobia Trial) |
| Study objectives | To determine whether a new, web-based version of cognitive therapy is an effective treatment for social phobia. |
| Ethics approval(s) | Approved by the Swiss National Science Foundation on 1 April 2006. |
| Health condition(s) or problem(s) studied | Social phobia |
| Intervention | 1. Web-based cognitive-behavioral treatment (10 weeks) 2. 10 week wait-list control condition Patients initially allocated to wait will subsequently receive the web-based cognitive-behavioral treatment. |
| Intervention type | Other |
| Primary outcome measure(s) |
The following will be performed at pre-assessment (baseline), post-assessment (at 10 weeks) and follow-up (at 6 months): |
| Key secondary outcome measure(s) |
The following will be performed at pre-assessment (baseline), post-assessment (at 10 weeks) and follow-up (at 6 months): |
| Completion date | 30/06/2008 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Sex | All |
| Target sample size at registration | 50 |
| Total final enrolment | 52 |
| Key inclusion criteria | 1. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) (American Psychiatric Association, 1994) criteria for social phobia. Assessed with the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders IV (SCID IV) 2. Patients are included if the cut off score is reached on the Social Phobia Scale and Social Interaction Scale 3. Age 18 to 35 4. Willing to accept random allocation |
| Key exclusion criteria | 1. Current or past psychosis 2. Borderline personality disorder (other personality disorders are not a reason for exclusion) |
| Date of first enrolment | 20/03/2007 |
| Date of final enrolment | 30/06/2008 |
Locations
Countries of recruitment
- Switzerland
Study participating centre
40 Blv. du Pont d'Arve
Geneva
1211
Switzerland
1211
Switzerland
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 01/10/2009 | 23/05/2019 | Yes | No |
| Study website | Study website | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
23/05/2019: Publication reference and total final enrolment added.